Á¦¸ñ
|
Á¦8ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
|
ÀÛ¼ºÀÚ
|
KCFKOREA
|
ÀÛ¼ºÀÏÀÚ
|
2019-04-09
|
Á¦8ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ °³ÃÖ Àå¼Ò : »ñÆ÷·Î½Ã(·ÎÀÌÆ° »ñÆ÷·Î) ÁÖÃÖ : AHCC ¿¬±¸È¸ ÈÄ¿ø : ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷ÈÇÐ ÇÑ ÇØ µ¿¾È AHCC¸¦ ¿¬±¸ÇÏ°í ±× ¼º°ú¸¦ º¸°íÇÏ´Â AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ°¡ 8ȸÂ÷¸¦ ¸Â¾Ò½À´Ï´Ù.Á¦8ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ¿¡¼´Â ÃÑ 20ÆíÀÇ ÀÏ¹Ý °¿¬ÀÌ ÁøÇàµÇ¾ú½À´Ï´Ù.¿©·¯ °¿¬ Áß °¨¿°, µ¿¹° Áúȯ¿¡ °üÇÑ °¿¬ÀÌ ¸¹Àº ÀÇ·á °ü°èÀÚµéÀÇ Èï¹Ì¸¦ À¯¹ßÇß½À´Ï´Ù.°¨¿°°ú AHCCÀÇ »ó°ü°ü°è¿Í µ¿¹°Áúº´¿¡¼ AHCCÀÇ Á¢¸ñ¿¡ ´ëÇÑ »õ·Î¿î °¡´É¼ºÀ» ½Ã»çÇÏ¿´½À´Ï´Ù. General Lecture General Lecture ¡°GCP: Genistein concentrated polysaccharide with anti-angiogenesis and anti-tumor activities in vitro and in vivo¡± Lan Yuan, et al. £¨Amino Up Chemical Co., Ltd., Japan£©¡°Studies on the inhibition of angiogenesis by GCP.¡± Paul F. Davis, et al. £¨Wellington School of Medicine, New Zealand£©¡°Various effects of the co-administration of AHCC and GCP in vitro and in vivo¡± Buxiang Sun, et al. £¨Amino Up Chemical Co., Ltd., Japan£©¡°Isoflavone, BRM and cancers¡± Robert M. Hackman £¨University of California, Davis, USA£©¡°Introduction of GCP studies conducted at Colombia University.¡± Michel Kiernan, et al. £¨Colombia University, USA£©¡°Preventive effect of AHCC on oxidative stress¡± Shigeru Matsuzaki, et al. £¨Dokkyo University School of Medicine£©¡°Preliminary report: Experience of AHCC on progressive, residual and recurrent cancer¡± Masaru Hagiwara, et al. £¨St.Mariana Medical University, Japan£©¡°Cancer Immunotherapy by Phyto-polysaccharide (AHCC):Its Effects and Strategy¡± Katsuaki Uno, et al. £¨Comfort Hospital, Japan£©¡°Inflammation Regulatory Effect of AHCC¡± Satoshi Yui, et al. £¨Teikyo University, Japan£©¡°Preventive effect of AHCC on opportunisitic infection and its mechanism¡± Shigeru Abe, et al. £¨Teikyo University, Japan£©¡°Augmentation canine of cellular immune response by administration of AHCC¡± Tadashi Takahashi, et al. £¨Nihon University, Japan£©¡°Application of the new immunotherapy using AHCC for animal disease I¡± Ayako Matuo, et al. £¨Nihon University, Japan£©¡°Application of the new immunotherapy using AHCC for animal disease II¡± Takashi Masuyama, et al. £¨Nihon University, Japan£©¡°Combination of AHCC and chemotherapy¡± Masuo Hosokawa, et al. £¨Hokkaido University, Japan£©¡°A clinical study for AHCC on chronic hepatitis patients¡± Mitsuaki Iwamoto £¨Ensannkai hospital, Japan£©¡°Effects of AHCC as a complementary treatment for postoperative hepatocellular carcinoma patients¡± Yoichi Matsui, et al. £¨Kansai Medical University, Japan£©¡°Case report: Inhibition of liver cirrhosis progression in a case of C type hepatitis with hepatocellular carcinoma¡± Morihiko Ishizaki, et al. £¨Kansai Medical University, Japan£©¡°Effect of AHCC on digestive cancer¡¡−especially for terminal cancer−¡± Yusai Kawaguchi, et al. £¨Kansai Medical University, Japan£©¡°Prospective,Randomized,Clinical Evaluation of QOL & Immune Index of Advanced, Metastatic Cancer Patients¡± Gye Hoon Ahn, et al. £¨Ok-Chern love Hospital, Korea£©¡°Role of AHCC as a Part of an Adult Disease Treatment Protocol¡± Fred Pescatore £¨The Centers for Integrative and Complementary Medicine, USA£©
|
Á¶È¸¼ö
|
253
|
|